Pharmacokinetics Flashcards

1
Q

What is ADME?

A

Absorption, distribution, metabolism, excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is IDE?

A

Input, distribution, elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Elimination =?

A

Metabolism, Excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why is ADME important?

A

ADME properties of a drug directly influence the concentration time profile in the body.

Time to peak concentration, peak concentration, time to be eliminated etc

This is important because concentration relates to drug effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pharmacokinetic and Pharmacodynamic plots

A

Conc/time = pharmacokinetic

Effect/Conc = pharmacodynamic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Reasons for failure in drug development

A

Clinical safety, efficacy, formulation, PK, commerical, toxicology, cost of goods, other

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Drug disposition diagram

A
  • Binding to plasma proteins
  • Reversible flow into other tissues
  • Binding and storage in tissues
  • Metabolism
  • Metabolites
  • Biliary excretion
  • Renal excretion
  • Rest of concentration at site of action -> pharmacological effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Major organs involved in ADME

A

Gastro-intestinal (GI) tract (absorption)

Liver (metabolism)

Kidney (excretion)

Lungs (absorption and excretion of volatile anaesthetic gases)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Drugs physico-chemical properties

A
  • Multiple physico-chemical properties of the drug can influence ADME processes
    • Solubility
    • Lipophilicity
    • Ionisation (pKa)
  • Chemical structure
    • Susceptibility to metabolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Membrane transport

A
  • Passive diffusion
  • Facilitated diffusion
  • Active transport
  • Endocytosis
  • Filtration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Passive diffusion

A
  • Most common mechanism for drug absorption
  • Driven by concentration gradient
    • At equilibrium unbound concentrations of drug on either side would be the same
  • Nonselective
  • Lipophilic, uncharged and small molecules pass easily
  • Small charged molecules like Na+ and Ca2+ don’t pass and instead are regulated by the cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Facilitated diffusion

A
  • Passive diffusion of drugs through transmembrane proteins
    • Driven by concentration gradient
  • Requires recognition by carrier or channel protein
    • e.g SLC transporters
  • Sugars and amino acids usual substrates
    • Less important for drugs
    • e.g tetracycline diffusion into bacteria
  • Rate is usually faster and can saturate
  • Can have competing ligands for the same transmembrane protein
  • Important in the tubules of the kidney, the GI tract etc
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Active transport

A
  • Uses cellular energy to transport drugs across membrane
    • Is not driven by concentration-gradient, can oppose concentration gradient
  • Requires recognition by membrane transporters
  • Drug transporters highly expressed in specific organs
    • Liver, kidney, blood brain barrier, gut epithelium
  • Active transport allows cell to:
    • Accumulate compounds essential for growth
    • remove waste products
    • Be protected against toxins
  • ATP binding cassete (ABC transporters)
    • Present in GI, brain and kideny, where they act to efflux from cell
    • Wide range of substrates, eg cyclosporine, digoxin
    • Can be induced and inhibited, e.g St Johns wort will induce transporter (source of DDIs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Endocytosis

A
  • Drugs is taken up by cell in vesicles (endocytosis)
    • Degraded in lysosomes
    • Released by cell (exocytosis)
  • Energy dependent
  • Mainly for drugs with MW > 1000 Da
    • E.g cytokines, hormones, growth factor, antibodies such as monoclonal antibodies, immunoglobulins, nano-formulations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Filtration

A
  • Most drugs pass through cells to cross biological barriers, except at:
  • Blood capillaries
    • Contain fenestrations that allow rapid interchange between blood and interstitial fluid
  • Glomerular capillaries (kidney)
    • Extremely porous allowing passage of all plasma constituents except macromolecules (MW > 30,000)
  • Some cells in the liver also have fenestrations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Routes of drug administration

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Drug absorption

A
  • Transfer of drug from administration site ot the systemic circulation
    • Requires passage through biological membranes
  • Drugs administered orally must be absorbed before they can cause their pharmacological effect
    • Several barriers to overcome, so absorption is usually delayed and incomplete
    • Big concentration on delivery side, low concentration inside the cell and in the circulation
  • Relevant for extravascular drug administration
    • ie oral (po), subcutaneous (sc), intramuscular (im), rectal (pr), sublingual (sl)
    • Not relevant for administration directly into system circulation (ie intravenous, i.v)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Absorption: Rate and Extent: 2 Things

A
  1. Rate: How rapidly the drug gets from the site of administration to the systemic circulation, Rate of absorption: IV < Inhalation < Intramuscular < Subcutaneous < Rectal/Sublingual < Oral < Topical < Transdermal
  2. Extent: How much of the administered dose enters the system circulation, bioavailability, F = 1: 100% enters arrives at circulation; F<1, incomplete absoprtion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Example of rate and extent of absorption on concentration profile

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Most popular routes of drug administration

A
  • Intravenous
    • Rate of absorption is immediate
    • Extent of absorption is 100%
  • Oral
    • Rate of absorption
    • Extent of absorption is incomplete
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

IV: Advantages & Disadvantages

A
  • Advantages
    • Very rapid
    • Precise control
    • Can be administered as bolus, infusion or both
    • No absorption involved (100% bioavailable)
    • Good for drugs that are too irritating to be taken by mouth or given by tissue injection
  • Disadvantages
    • Required hospitalisation
    • Careful preparation of injected material (sterile, non-particulate)
    • Most hazardous (no recall if you give too much)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Oral (po) administration

A
  • Most common route
    • 80% of all prescriptions
  • Advantages
    • Safest, most convenient & economic
  • Disadvantages
    • Slow (1/2 - 3h for effect)
    • Unpredictable with regard to:
      • Rate
      • Extent
      • Reproducibility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Absorption sites in GI tract

A
  • Oral mucosa
    • Thin epithelium and highly vascularised but limited absorption due to short contact time
  • Oesophagus
    • No absorption due to rapid transit time
  • Stomach
    • Acidic pH, small surface area (0.5 m2) and is lined by a thick mucus layer
    • Absorption site for weak acids and neutral drugs
  • Small intestine
    • Major site of drug absorption
    • Have villi which provide extremely large surface area (200m2) and are very vascular with 1/3 of cardiac output
  • Large intestine
    • Little absorption
    • Colon microbiota and metabolising enzymes can break down drug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Factors affecting GI absorption of oral drugs

A
  • Drug characteristics
    • Dosage form: tablet, capsule, liquid, coating
    • Dissolution rate
    • Water and lipid solubility
    • Ionisation - if ionises, slow absorption as needs transporter
    • Chemical stability
    • Liability for metabolism
  • Patient characteristics
    • Gastric emptying rate
    • Intestinal motility
    • Drug-food interactions in the gut
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Gastric empyting rate

A
26
Q

Intestinal motility

A
  • The time taken for drugs to pass through the GI tract affects their absorption
    • Stomach: 2-5h
    • Small intestine: 3-4h
    • Large intestine: 10h - days
  • Disease state can influence intestinal motility
    • E.g diarrhea, gasteroenteritis, irritable bowel syndrome
  • High motility can prevent adequate absorption
    • Particularly for poorly water soluble drugs e.g digoxin
  • Low motility can expose the drug to gut metabolism
  • Gut motility can be impacted by other drugs
27
Q

Drug-food interactions in the gut

A
  • Drugs may interact with food in the GI tract
    • This can affect rate and extent of drug absorption
  • Grapefruit juice can affect the metabolism of co-administered drugs
  • Tetracycline and dairy products or divalent/trivalent metal ions
    • Forms insoluble complex with metal ions, reducing absorption
28
Q

What is drug distribution?

A
  • Transfer of drug from blood circulation to various tissues in the body
    • Distributes into interstitial and intracellular fluids
  • Essential for drug to get to its site of action
29
Q

Capillary permeability

A
  • Most capillaries are relatively porous
    • Thus drugs leave the blood regardless whether they are poorly lipid soluble, charged or polar
  • Exception: brain capillaries have no pores and an additional layer of glial cells - known as blood brain barrier
    • only lipid soluble drugs diffuse across brain capillaries into the brain (unless they undergo active transport)
30
Q

Body fluid compartments and molecular weight of drugs

A
  • Water soluble drugs restricted to extracellular fluid
  • Lipid soluble/non-ionised drug can diffuse into the intracellular fluid
  • High molecular weight drugs confined to plasma
31
Q

Drug distribution & blood flow

A
  • Tissue that recieves more blood recieves more drug
  • Rate of distribution to tissues depends on relative blood flow:
    • Heart, lungs, brain, liver and kideny receive drug very rapidly
    • Slower rate to less well perfused organs, such as muscle, skin and fat
32
Q

Plasma protein binding effect on drugs

A
  • Drugs frequently bind to proteins in the plasma
    • e.g albumin, a1-acid-glycoprotein, steroid hormone binding globulins
  • Bound drug will remain in circulation
    • Is pharmacologically inactive
    • Is protected from metabolism and excretion
    • Binding is usually reversible and rapid
  • Binding to tissue proteins may also influence where drugs collect (e.g digoxin, myocardium and skeletal muscle)
33
Q

Outcomes of drug metabolism

A

Metabolism is the biotransformation of drugs. Enzyme causes a chemical change to the drug molecule; either building molecule up or breaking it down

  • Plays a vital role in drug elimination
    • = metabolism + excretion
    • altering the chemical structure of the molecule often means its ability to move around the body is altered (easier to excrete), or a change in its effects (ability to bind to receptors)
  • Metabolism often terminates drug activity, but can also cause
    • Increased drug activity
      • Activation of prodrug (e.g acetylsalicyclic acid aka aspirin -> salicylate
    • No change in activity
      • Metabolite is also biologically active (e.g diazepam -> nordiazepam
    • Production of toxic or carcingenic metabolites
      • e.g paracetamol -> NAPQI
34
Q

Possible sites of drug metabolism

A
  • Liver
    • Major site of drug metabolism
  • Intestinal wall
    • CYP450 enzymes
  • GI tract
    • Gut bacteria and proteases
  • Plasma
    • Esterases (prodrug activation, metabolism)
  • Lungs
    • Metabolism of aerosol sprays
35
Q

Liver metabolism diagram

A
36
Q

Metabolism reactions (require that the substrate, enzyme and any cofactors are in high supply)

A
  • Oxidation
    • Increase proportion of oxygen on the molecule
  • Reduction
  • Hydrolysis
    • Water molecule is added to compound, usually resulting in bond cleavage (ORH = phase 1 reaction)
  • Conjugation (phase 2 reaction)
    • Addition of endogenous substrate
    • Usually increase molecular mass, polarity, water solubility = easier to excrete as it is not as mobile
    • Glucuronidation, sulphation, acetylation, glutathionylation

Enzymatic metabolism may occur sequentially, may compete, or may not occur at all; opportunistic or parallel

37
Q

Oxidation

A
  • CYP450 family most important oxidative enzymes
    • cytochrome P450 dependent mixed function oxidases
    • located mainly on the smooth endoplasmic reticulum, some around the mitochondria
  • Oxidation can occur by other enzymes
    • Alcohol dehydrogenase
    • Aldehyde dehydrogenase
    • Aromatase
    • Amine oxidases
    • and others
38
Q

CYP450 family

A
  • Superfamily of more than 20 gene families in humans, just 4 isoforms responsible for majority of phase I oxidative reactions (CYP3A4, CYP2D6, CYP2C9 and CYP2C19)
  • Requires O2, NADPH and cytochrome P450 reductase
  • Five features of CYP oxidation
  1. Substrate binding
  2. Oxygen binding
  3. Oxygen splitting
  4. Inserting oxygen into substrate
  5. Release of the metabolite
39
Q

CYP3A4 nomenclature

A

CY = cytochrome

P = p450

3 = Family

A = Subfamily

4 = Isoform

40
Q

Factors influencing drug metabolism

A

Organ function - Liver, Kidney, Heart, Gut

Patient - genetic, constitution

Diseases other drugs

Diet, Cigarettes, Alcohol

Age, Sex, Pregnancy

41
Q

Drug excretion

A
  • The process by which drugs are removed from the body
  • The kidney is the most important organ for drug excretion
    • Expelled in the urine
    • 3 processes
      • Glomerular filtration
      • Tubular secretion
      • Tubular reabsorption
  • Other forms of excretion include:
    • Bililary excretion
      • Larger molecules > 400 daltons and ionised
    • Faecal excretion of non-absorbed drug
    • Excretion through tears, respiration, sweat, milk, saliva
42
Q

Role of Kidneys

A
  • Regulated volume & composition of body fluids
  • Conserve essential compounds and remove waste products
  • Specialised transport systems
    • e.g for electrolytes, glucose and amino acids
  • Removes water soluble drugs and metabolites
    • dependent on physico-chemical properties
  • Lipophilic drugs and metabolits usually retained
    • Same properties that allow them to move around the body often prevent them from being excreted
43
Q

Drug excretion at the kidney, process summary

A
  • Small molecules that can fit through glomerular will pass through easily
    • Larger molecules will not filtered
    • Bound to plasma proteins = cannot pass
  • Active transport in tubules will pump substrates into lumen
    • Creates a high concentration that promotes reabsorption
    • Ionised, large and polar molecules can be pumped in that way
  • Once inside the lumen of the tubules
    • Lipophilic, non-ionised drug that will be reabsorbed into surrounding capillaries using the concentration gradient and escape excretion
    • Hydrophilic & ionised drug will not be able to reabsorbed, these will be excreted in the urine
44
Q

Factors that influence renal drug excretion

A
  • Body size
  • Age
    • Renal function decreases 50% with age (25-75yr)
    • GFR only about 30% in a term neonate
  • Pregnancy
    • Renal function increases 50%
  • Disease
    • Renal disease, heart disease
  • Other medications
45
Q

Summary of ADME diagram

A
46
Q

Concentration-time curve after oral dose: Exposure

A

Exposure = Area under conc-time curve (AUC)

Typical units = mg.h/l

47
Q

Oral vs IV PK diagram

A
48
Q

Oral bioavailability

A
  • Not all drug reaces the systemic circulation after oral dosing
    • Partial absorption
    • First pass metabolism
  • Bioavailabilty reflects the fraction of dose that reaches the systemic circulation
    • Calculated relative to IV PK
  • F = (AUC po / AUC IV) x (dose IV/dose po)
  • Ideally F should be >20% for drug to be given orally
  • Assuming clearance = same
49
Q

How can rate be estimated?

A

Tabs, the absorption half life (units, h-1)

Long Tabs, slow absorption. Fast Tabs, fast absorption

Another way to compare rate is to look at the time of peak concentration (Tmax - a PK variable we can measure from the plot)

50
Q

Drug distribution: Volume of Distribution

A
  • The reversible movement of drug between body compartments once it has entered the system circulation
  • Defined/quantified by the parameter volume of distribution (VD)
    • Proportionality constant between the dose we give and concentration we measure
51
Q

Volume of distribution: Equation and Factors

A

VD= (amount of drug in the body (mg))/ (plasma drug concentration (mg/L))

  • Determined by:
    • Body mass and composition
    • Tissue blood flow
    • Tissue binding - increase in volume of distribution
    • Plasma protein binding - decrease in volume of distribution
    • Physico-chemical properties of the drug
      • e.g lipophilicity
    • Natural barriers (e.g blood brain barrier)
52
Q

Loading dose (LD)

A
  • Initial dose administered to achieve a target concentration rapidly
    • Dependent on Vd
    • Helps to fill bath (Vd) faster to rapidly achieve the target concentration
    • The bigger the Vd the higher the dose required to achieve target concentration
  • Loading dose (mg) = Vd (L) x target concentration (mg/L)
  • If no loading dose is used, the volume takes time to fill up, so the larger the Vd, the longer the time to reach the target conc
  • Usually given as IV bolus so that target conc is reached quickly, then maintained by IV infusion, but oral loading doeses can also be used
53
Q

Clearance (CL)

A
  • A constant that describes the relationship between drug concentration and the rate of elimination
  • Clearance L/h = elimination rate (mg/h) / concentration (mg/L)
  • Can also estimate it from Clearance (L/h) = Dose / AUC
  • Plasma clearance = sum of clearances from individual organs
54
Q

Maintenance dose rate

A
  • Dose rate to achieve and maintain a target concentration
    • Steady state concentration (Css)
  • At steady state, plasma concentrations remain constant. This occurs when the rate of drug elimination is equal to the rate of input
  • Maintenance dose rate = Clearance x target concentration
  • mg/h = L/h x mg/L
  • A rapidly cleared drug will need a large maintenance dose to keep drug concs at target levels
55
Q

Maintenance dose calculation - repeat oral dosing

A
  • Account for F (bioavailability) and DI (dosing interval) at once daily dosing (24 hourly)
  • CL x Css x DI = F x Dose
56
Q

Half life (T1/2)

A
  • Time required for drug concentration to fall by half
  • Depends on VD and CL
  • T1/2 = 0.7 x VD/CL
  • Usually a constant irrespective of drug concentration
  • The amount of drug in the body at any time is related to the number of half-lives from drug administration
  • If the half-life is known, then it is possible to estimate:
    • How much drug is left in the body
    • How long it will take to reach steady state
  • A drug with a long-half life will take a long time to reach steady state
    • cannot be reduced by increasing the dose
57
Q

Accumulation

A
  • With repeated dosing or infusion, drug will accumulate in the body until input rate = elimination rate
  • Steady state occurs when drug accumulation is complete and concentrations have plateaued
  • The time required to reach steady state is related to half-life
    • Accumulation is >90% complete after 4 half-lives
    • Generally agreed that steady state is reached after 4-5 half-lives
    • If wait>5 half-lives before re-administration, drug will not accumulate
58
Q

Accumulation to Css graph

A
59
Q

Accumulation calculation

A
  • Aim to achieve target concentration at steady state with constant rate IV infusion of theophylinne in an asthma patient
  • How long will it take to reach target concentration?
    • After 4 half-lives >90% of the drug’s steady state
    • Therefore time required = 4 x 9 = 36h
  • What if theophylline had a smaller Vd of only 5L?
    • T1/2 = 0.7 x 5/2.8 = 1.3h
    • Time required = 5.2h
    • smaller bathtub, less fill time!
60
Q

Sensible adjustment of dosing rates for changes in CL

A

Elimination may be impacted by body size, immaturity, old age, drug interactions, pathology of the liver, kideny, cardiovascular system.. etc, etc

captured by CL & this allows sensible dose adjustment